Archive for the ‘Nascent Biotech’ Category

Nascent Biotech and Mapp Biopharmaceuticals

March 6th, 2015 | Posted in 2015, Mapp BIopharmaceuticsl, Nascent Biotech

Nascent Biotech and Mapp Biopharmaceuticals, were awarded a joint $225,000 Small Business Innovative Research grant to collaborate on using tobacco plants as an adjunct expression systems for Nascent’s Pritumumab, a monoclonal antibody for the treatment of brain cancer.